Cardiovascular Revascularization Medicine
Volume 11, Issue 1 , Pages 52-56 , January 2010

Late drug-eluting stent thrombosis: importance of intravascular ultrasound

Received 18 August 2008 ,Revised 21 December 2008 ,Accepted 22 December 2008.

References 

  1. van Werkum JW, Dekorte FI, Heestermans AA. High recurrence rates after a first episode of stent thrombosis: results from the Dutch Stent Thrombosis Study. In: American College of Cardiology Scientific Sessions/i2 Summit-SCAI Annual Meeting; March 29, 2008; Chicago, IL. 2008;
  2. Okabe T, Mintz GS, Buch AN, Roy P, Hong YJ, Smith KA, et al Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. Am J Cardiol. 2007;100(4):615–620
  3. Fujii K, Carlier SG, Mintz GS, Yang YM, Moussa I, Weisz G, et al Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol. 2005;45(7):995–998
  4. Alfonso F, Suarez A, Perez-Vizcayno MJ, Moreno R, Escaned J, Banuelos C, et al Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis. J Am Coll Cardiol. 2007;50(21):2095–2097
  5. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115(18):2426–2434
  6. Popma JJ, Weiner B, Cowley MJ, Simonton C, McCormick D, Feldman T. FDA advisory panel on the safety and efficacy of drug-eluting stents: summary of findings and recommendations. J Interv Cardiol. 2007;20(6):425–446
  7. Nakamura S, Colombo A, Gaglione A, Almagor Y, Goldberg SL, Maiello L, et al. Intracoronary ultrasound observations during stent implantation. Circulation. 1994;89(5):2026–2034
  8. Roy P, Steinberg DH, Sushinsky SJ, Okabe T, Pinto Slottow TL, Kaneshige K, et al The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J. 2008;29(15):1851–1857
  9. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369(9562):667–678
  10. Chieffo A. Influence of prolonged dual anti-platelet use on late stent thrombosis in a large real-world registry: the Milan/Siegburg/Naples Experience. In: Presented at Transcatheter Cardiovascular Therapeutics Meeting; October 22–27, 2006; Washington DC. 2006;

PII: S1553-8389(09)00036-0

doi: 10.1016/j.carrev.2008.12.006

Cardiovascular Revascularization Medicine
Volume 11, Issue 1 , Pages 52-56 , January 2010